Miracle Mile Advisors’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$539K Buy
14,726
+513
+4% +$18.6K 0.01% 603
2026
Q2
$503K Sell
14,213
-31
-0.2% -$916 0.01% 617
2026
Q1
$395K Sell
14,244
-48
-0.3% -$1.23K 0.01% 647
2025
Q4
$310K Buy
14,292
+100
+0.7% +$1.97K ﹤0.01% 697
2025
Q3
$215K Buy
14,192
+40
+0.3% +$495 ﹤0.01% 777
2025
Q2
$159K Buy
14,152
+1,652
+13% +$17.9K ﹤0.01% 700
2025
Q1
$126K Hold
12,500
– – ﹤0.01% 622
2024
Q4
$148K Buy
+12,500
New +$148K ﹤0.01% 612

Other funds holding ROIV

Miracle Mile Advisors's ROIV Position: Q3 2026 in Review

Miracle Mile Advisors increased its Roivant Sciences (ROIV) stake by 3.6% in Q3 2026, buying an estimated $18.6K and bringing the position to 14,726 shares worth $539K. The position accounts for 0.01% of the portfolio, ranked #603.

Miracle Mile Advisors first reported a position in ROIV in Q4 2024 and has held it in 8 quarters since. 268 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Miracle Mile Advisors held 14,726 shares of Roivant Sciences worth $539K as of Q3 2026.
  • Miracle Mile Advisors bought 513 Roivant Sciences shares in Q3 2026, an estimated $18.6K.
  • Roivant Sciences made up 0.01% of Miracle Mile Advisors's portfolio in Q3 2026, its #603 holding.
  • Miracle Mile Advisors first reported a position in Roivant Sciences in Q4 2024 and has held it in 8 quarters since.
  • 268 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Miracle Mile Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.